$TRU

TransUnion Reports 12% Revenue Growth in Q3, Raises Full-Year 2026 Earnings Guidance

TransUnion reported Q3 adjusted EPS of $1.25, beating estimates, with revenue up 12% YoY to $1.31B. The company raised its 2026 EPS guidance to $4.81-$4.88 and maintained revenue outlook. Shares fell 0.28% premarket.

Original reporting
Published Oct 27, 2026, 2:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 3:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TransUnion Reports 12% Revenue Growth in Q3, Raises Full-Year 2026 Earnings Guidance — source image
Decision brief

The 30-second read

$TRUBullishHigh
01

Why it matters

Earnings beat, 12% revenue growth, and a higher EPS outlook may attract buying interest, while the small price dip suggests caution.

02

Market read

The earnings beat and guidance raise are material for investors in credit‑reporting and data‑services stocks.

03

What to watch

Rising interest rates may limit future earnings growth despite the guidance bump.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

TransUnion, a leading consumer‑credit reporting firm, released its Q3 2026 results and updated full‑year guidance.

Company-level read

Ticker impact

$TRUBullishMedium confidence
Context

TransUnion reported Q3 earnings beat and raised full-year 2026 EPS guidance to $4.81-$4.88.

Expected impact

likely modest upside as the market prices in higher guidance despite a small pre‑market dip

Evidence & confidence

The beat and guidance lift fundamentals, while the 0.28% pre‑market decline suggests limited immediate buying pressure.

Market effects

Stronger credit‑reporting earnings may boost sentiment in the data‑services sector.

U.S. investors may view the guidance raise as a positive signal for consumer‑finance exposure.

International revenue growth, especially in India, underscores global demand for credit data.

Counterpoint

The modest pre‑market decline could signal that the guidance raise is already priced in.

Key entities

  • Chris Cartwright

    President and CEO of TransUnion, commented on the results and outlook.

Related articles

$TRUHighAI 8/10

TransUnion (TRU) (Q3 2026) Earnings Call Highlights: Revenue and EPS Beat Guidance

TransUnion (TRU) reported Q3 2026 earnings beating guidance with 8% revenue growth and 14% EPS growth. International business grew 10%, led by India and Latin America. The company reduced its leverage ratio and increased share repurchase authorization. However, rising interest rates are expected to slow mortgage volumes and auto affordability, leading to a sequential deceleration in revenue growth to 3-6% in Q4. Legal and regulatory expenses also contributed to margin contraction.

$TRUHighAI 8/10

TransUnion (TRU) Q3 2026 Earnings Call Transcript

TransUnion (TRU) reported Q3 2026 organic revenue growth of 8%, with adjusted EPS up 14%. U.S. Markets revenue rose 7%, while international revenue grew 10%, led by India and Latin America. The company repurchased $126M in shares and raised its repurchase authorization by $1B. Despite economic uncertainties, TRU raised its full-year guidance, expecting 8-9% revenue growth and 12-13% adjusted EPS growth.

$TRUMed

TransUnion Q3 2026 Earnings Call Summary

TransUnion reported Q3 2026 earnings, highlighting 18% growth in India and Latin America, 13% auto growth, and 10% international growth. The company expects full-year share repurchases of $500M and plans to expand its OneTru platform globally. Management noted resilience in US Financial Services despite inflation and higher interest rates, and provided guidance for Q4, including potential impacts from regulatory changes and market softening.

$TRUHighAI 8/10

TransUnion Q3 2026 slides: insurance drives growth amid margin pressure

TransUnion (TRU) reported Q3 2026 earnings with revenue of $1.31B, matching estimates, and EPS of $1.25, beating forecasts. Revenue grew 8% organically, driven by insurance and international markets. However, adjusted EBITDA margin contracted by 90 basis points to 35.4%. The company raised full-year guidance, expecting 8-9% revenue growth and 12-13% EPS growth. Shares fell 2.19% in premarket trading.